Synergistic effects of bismuth thiols and various antibiotics against Pseudomonas aeruginosa Biofilm

Jundishapur Journal of Microbiology

Volumn 7, Issue 3, 2014, Pages

  Varposhti, Maryam ^a   Abdi Ali, Ahya ^a   Mohammadi, Parisa ^a  

^a ALZAHRA UNIVERSITY   (Iran)

Author keywords

Antibacterial agents; Biofilms; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BISMUTH ETHANEDITHIOL; BISMUTH PROPANE DITHIOL; BISMUTH THIOL DERIVATIVE; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BIOFILM; COLORIMETRY; CONTROLLED STUDY; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 84896483080     PISSN: 20083645     EISSN: 20084161     Source Type: Journal    
DOI: 10.5812/jjm.9142     Document Type: Article

References (26)

1. de Bentzmann S, Plesiat P. The Pseudomonas aeruginosa opportunistic pathogen and human infections. Environ Microbiol. 2011; 13(7): 1655-65.
2. Khan F, Shukla I, Rizvi M, Mansoor T, Sharma SC. Detection of biofilm formation in Staphylococcus aureus. Does it have a role in treatment of MRSA infections? Trends Med Res. 2011; 6(2).
3. Mahami T, Adu-Gyamfi A, Owulah C. Comparative susceptibility of in vitro biofilm and planktonic cells of Staphylococcus aureus to antimicrobials. Afr J Microbiol Res. 2010; 4(12): 1209-14.
4. Van Eldere J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother. 2003; 51(2): 347-52.
5. Cornelis P. Pseudomonas aeruginosa: Genomics and Molecular Biology. 1st edUK: Casister Academic Press; 2008.
6. Domenico P, Salo RJ, Novick SG, Schoch PE, Van Horn K, Cunha BA. Enhancement of bismuth antibacterial activity with lipophilic thiol chelators. Antimicrob Agents Chemother. 1997; 41(8): 1697-703.
7. Domenico P, O'Leary R, Cunha BA. Differential effects of bismuth and salicylate salts on the antibiotic susceptibility ofPseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 1992; 11(2): 170-5.
8. Domenico P, Tomas JM, Merino S, Rubires X, Cunha BA. Surface antigen exposure by bismuth dimercaprol suppression of Klebsiella pneumoniae capsular polysaccharide. Infect Immun. 1999; 67(2): 664-9.
9. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med. 1988; 85(3): 307-14.
10. Abdi-Ali A, Mohammadi-Mehr M, Agha Alaei Y. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa. Int J Antimicrob Agents. 2006; 27(3): 196-200.
11. Bajaksouzian S, Visalli MA, Jacobs MR, Appelbaum PC. Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrob Agents Chemother. 1997; 41(5): 1073-6.
12. Tunney MM, Ramage G, Field TR, Moriarty TF, Storey DG. Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2004; 48(5): 1879-81.
13. Lewis RE, Diekema DJ, Messer SA, Pfaller MA, Klepser ME. Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species. J Antimicrob Chemother. 2002; 49(2): 345-51.
14. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003; 52(1): 1.
15. Shih PC, Huang CT. Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. J Antimicrob Chemother. 2002; 49(2): 309-14.
16. Acar JF. Antibiotic synergy and antagonism. Med Clin North Am. 2000; 84(6): 1391-406.
17. Domenico P, Baldassarri L, Schoch PE, Kaehler K, Sasatsu M, Cunha BA. Activities of bismuth thiols against staphylococci and staphylococcal biofilms. Antimicrob Agents Chemother. 2001; 45(5): 1417-21.
18. Huang CT, Stewart PS. Reduction of polysaccharide production in Pseudomonas aeruginosa biofilms by bismuth dimercaprol (BisBAL) treatment. J Antimicrob Chemother. 1999; 44(5): 601-5.
19. Langley S, Beveridge TJ. Effect of O-side-chain-lipopolysaccharide chemistry on metal binding. Appl Environ Microbiol. 1999; 65(2): 489-98.
20. Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002; 34(5): 634-40.
21. Ohge H, Furne JK, Springfield J, Sueda T, Madoff RD, Levitt MD. The effect of antibiotics and bismuth on fecal hydrogen sulfide and sulfate-reducing bacteria in the rat. FEMS Microbiol let. 2003; 228(1): 137-42.
22. Nelson JM, Chiller TM, Powers JH, Angulo FJ. Fluoroquinoloneresistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story. Clin Infect Dis. 2007; 44(7): 977-80.
23. Hooper DC. Mechanisms of fluoroquinolone resistance. Drug Resist Updat. 1999; 2(1): 38-55.
24. Shemesh M, Kolter R, Losick R. The biocide chlorine dioxide stimulates biofilm formation in Bacillus subtilis by activation of the histidine kinase KinC. J Bacteriol. 2010; 192(24): 6352-6.
25. Ryan RP, Dow JM. Diffusible signals and interspecies communication in bacteria. Microbiology. 2008; 154(Pt 7): 1845-58.
26. Baddour LM, Yu VL, Klugman KP, Feldman C, Ortqvist A, Rello J, et al. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004; 170(4): 440-4.